Carey Danis & Lowe Investigates Alleged Risperdal Side Effect Male Breast Growth

A pharmaceutical product liability litigation firm, Carey Danis & Lowe, is currently investigating an alleged Risperdal side effect, male breast growth. In February, the law firm launched an online Risperdal information center. St. Louis, MO (PRWEB) March 11, 2014 The St. Louis pharmaceutical lawyers at Carey Danis & Lowe are currently investigating an alleged Risperdal side effect, male breast growth, medically termed gynecomastia. Carey Danis & Lowe represents plaintiffs who have filed lawsuits against Risperdal manufacturer, Janssen Pharmaceuticals, an arm of Johnson & J
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories